COURTNEY HAWKINS: Open Payments
NPI 1013618719 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 78 payments from 12 companies in 2025. Trend: 2023 $836 · 2024 $1,843 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $246 |
| Lilly USA, LLC | 14 | $207 |
| AstraZeneca Pharmaceuticals LP | 8 | $203 |
| ABBVIE INC. | 20 | $197 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| PFIZER INC. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Medtronic, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: MOUNJARO, VRAYLAR, Ozempic, Kerendia, FARXIGA, AIRSUPRA, TZIELD, Wegovy.
Industry payments across GA — which companies pay providers there.
